Disentangling the effects of race on breast cancer treatment

Cancer

Volumn 110, Issue 10, 2007, Pages 2169-2177

  Banerjee, Mousumi ^a   George, Julie ^b,c   Yee, Cecilia ^c   Hryniuk, William ^d   Schwartz, Kendra ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d Cancer Advocacy Coalition of Canada   (Canada)

Author keywords

Breast cancer; Comorbidity; Health insurance; Racial disparity; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DISTRIBUTION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PATIENT EDUCATION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BREAST NEOPLASMS; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MIDDLE AGED; SOCIAL CLASS; SOCIAL JUSTICE; TREATMENT OUTCOME;

EID: 36049010296     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23026     Document Type: Article

References (42)

1. American Cancer Society. Cancer Facts and Figures 2006. Atlanta, Ga: American Cancer Society; 2006.
2. Ries LAG, Eisner MP, Kosary CL, et al. eds. SEER Cancer Statistics Review, 1973-1998. Bethesda, Md: National Cancer Institute; 2001.
3. Garfinkel L, Boring CC, Heath CW Jr. Changing trends: an overview of breast cancer incidence and mortality. Cancer. 1994;74:222-227.
4. Russell A, Langlois T, Johnson G, Trentham-Dietz A, Remington P. Increasing gap in breast cancer mortality between black and white women. WMJ. 1999;98:37-39.
5. Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin. 2000;50:50-64.
6. Chu KC, Tarone RE, Brawley OW. Breast cancer trends of black women compared with white women. Arch Fam Med. 1999;8:521-528.
7. Jatoi I, Anderson WF, Rao SR, Devesa SS. Breast cancer trends among black and white women in the United States. J Clin Oncol. 2005;23:7836-7841.
8. Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst. 2002;94:471-473.
9. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198-1205.
10. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.
11. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999;91:1487-1491.
12. Roach M, Cirrincione C, Budman D, et al. Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541. Cancer J Sci Am. 1997;3:107-112.
13. Dignam JJ, Redmond CK, Fisher B, Costantino JP, Edwards BK. Prognosis among African-American women and white women with lymph node negative breast carcinoma: findings from 2 randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). Cancer. 1997;80:80-90.
14. Muss HB, Hunter CP, Wesley M, et al. Treatment plans for black and white women with stage II node-positive breast cancer. Cancer. 1992;70:2460-2467.
15. Michalski TA, Nattinger AB. The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries. Cancer. 1997;79:314-319.
16. Velanovich V, Yood MU, Bawle U, et al. Racial differences in the presentation and surgical management of breast cancer. Surgery. 1999;125:375-379.
17. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94:490-496.
18. Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24:1357-1362.
19. Chen VW, Correa P, Kurman RJ, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1994;3:127-135.
20. Joslyn SA. Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat. 2002;73:45-59.
21. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294:1765-1772.
22. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
23. Bickell NA, Chassin MR. Determining the quality of breast cancer care: do tumor registries measure up? Ann Intern Med. 2000;132:705-710.
24. Du XL, Key CR, Osborne C. Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997. Breast J. 2004;10:433-439.
25. Henson DE, Ries L, Shambaugh EM. Survival results depend on the staging system. Semin Surg Oncol. 1992; 8:57-61.
26. Krieger N, Quesenberry C, Peng T, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, black, Hispanic, and white residents of the San Francisco Bay Area, 1988-1992. Cancer Causes Control. 1999;10:525-537.
27. Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97:134-147.
28. Jatoi I, Becher H, Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare system. Cancer. 2003;98:894-899.
29. Du W, Simon MS. Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat. 2005;91:243-248.
30. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effects of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285:885-892.
31. Velanovich V, Gabel M, Walker EM, et al. Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients. J Am Coll Surg. 2002;194:8-13.
32. Wyld L, Garg DK, Kumar ID, Brown H, Reed MW. Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines. Br J Cancer. 2004;90:1486-1491.
33. Kummel S, Elling D, Jeschke S, Schmid P, Thomas A. Chemotherapy treatment options for elderly women with breast cancer. Anticancer Res. 2006;16:1673-1676.
34. Neale AV, Tilley BC, Vernon SW. Marital status, delay in seeking treatment and survival from breast cancer. Soc Sci Med. 1986;23:305-312.
35. Goodwin JS, Hunt WC, Key CR, Samet JM. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA. 1987;258:3125-3130.
36. Du X, Freeman JL, Goodwin JS. The declining use of axillary dissection in patients with early stage breast cancer. Breast Cancer Res Treat. 1999;53:137-144.
37. King MT, Kenny P, Shiell A, Hall J, Boyages J. Quality of life 3 months and 1 year after first treatment for early stage breast cancer: influence of treatment and patient characteristics. Quality Life Res. 2000;9:789-800.
38. Blackman SB, Lash TL, Fink AK, Ganz PA, Silliman RA. Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients. Cancer. 2002;95:2465-2472.
39. Silliman RA, Troyan SL, Guadagnoli E, Kaplan SH, Greenfield S. The impact of age, marital status, and physician patient interactions on the care of older women with breast carcinoma. Cancer. 1997;80:1326-1334.
40. Yellen S, Cella DF. Someone to live for: social well-being, parenthood status, and decision-making in oncology. J Clin Oncol. 1995;13:1255-1264.
41. Lincoln KD, Chatters LM, Taylor RJ. Social support, traumatic events, and depressive symptoms among African Americans. J Marriage Fam. 2005;67:754-766.
42. Riley GF, Potosky AL, Mabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA. 1999;281:720-726.